---
nav_exclude: true
title: "Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir/Ritonavir Treatment in Randomized, Double-Blind, Placebo-Controlled Trials - United States and International Sites, 2021-2022"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=740688"
source_layer: us_cdc_mmwr
category: case_series
date: 2023-12-21
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes  data from two randomized, double-blind clinical trials that investigated COVID-19 rebound following treatment with or without nirmatrelvir/ritonavir. 

## 詳細內容

This report describes  data from two randomized, double-blind clinical trials that investigated COVID-19 rebound following treatment with or without nirmatrelvir/ritonavir. 

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:10:21Z*
*資料來源: CDC MMWR*
